Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT04378998 Completed - Terminal Illness Clinical Trials

Is Acupuncture Able to Reduce Nausea and Vomiting in the Terminal Ill Patient

Start date: January 25, 2015
Phase: N/A
Study type: Interventional

A comparative effectiveness research design was used. The sample size was calculated to 136 patients, who were randomized to an intervention group and a control group respectively. The patients were terminal ill patients enrolled to three in-bed hospices in Denmark and nausea and vomiting were measured using EORTC QlQ-c15-PAL (European Organisation for Research and Treatment of Cancer, Quality of Life Questionaire, core 15, Palliation)

NCT ID: NCT04342780 Completed - Clinical trials for Chemotherapy-induced Nausea and Vomiting

Prevalence of Delayed Chemotherapy Associated Nausea

CINrate
Start date: June 29, 2020
Phase:
Study type: Observational

This study evaluates the prevalence of delayed chemotherapy induced nausea in adult oncology patients in real clinical practice of day clinics.

NCT ID: NCT04329637 Completed - Clinical trials for Cyclic Vomiting Syndrome

Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS

Start date: October 5, 2016
Phase: N/A
Study type: Interventional

Cyclic vomiting syndrome is a chronic functional gastrointestinal disorder that is a significant health care problem. It affects 1-2% of the population and imposes an enormous burden on patients, families and the health care system. Due to the recalcitrant nature of the disease, patients have high rates of health care utilization with multiple emergency department visits and hospitalizations. These in turn lead to school and work absenteeism, job loss, divorce and even disability. CVS is also associated with multiple comorbid conditions such as anxiety and depression, which further contribute to disease severity. Both neuroimaging studies and other data demonstrate the role of the central nervous system in the pathophysiology of CVS with stress being a significant trigger for episodes of CVS. In summary, CVS is common, disabling and expensive and is associated with significant psychosocial comorbidity that contributes to impaired quality of life . Our current healthcare delivery model is disease-centric and does not adequately address the psychosocial barriers that contribute to poor health in this patient population. We propose a novel, collaborative, integrative health care model that shifts the paradigm of care from one that is episodic and disease-centered to a patient-centered approach that addresses psychosocial determinants of health not addressed in our current traditional health care system. We will incorporate meditation practices that have been shown to reduce psychological distress and also add a care coordinator to our health care delivery team. The primary role of the care coordinator is to identify patient goals, preferences and barriers to self-management and address psychosocial and environmental issues that determine health. Patients will be randomized to either the integrative health care model or usual care. The primary aim of our study is to determine the impact of our proposed integrative health care model on health care outcomes which will include a reduction in psychological distress, improvement in coping skills for managing chronic disease, cognitive symptom management, improvement in health-related quality of life and reduction in health care utilization. This collaborative effort between physicians, community partners, and allied health personnel will redesign the health care delivery system, facilitate access to appropriate healthcare services, optimize chronic disease management and improve overall healthcare outcomes.

NCT ID: NCT04294108 Completed - Atrial Fibrillation Clinical Trials

Why in Hospital After VATS Lobectomy

Start date: April 20, 2020
Phase:
Study type: Observational

The study aims to identify specific or potential reasons that prolong the length of hospital stay after video-assisted thoracoscopic surgery lobectomy. The hypothesis is that patients who are still in hospital after video-assisted thoracoscopic surgery lobectomy are associated with prolonged air leak, infection, pneumonia, atrial fibrillation or other complications or social factors.

NCT ID: NCT04287595 Completed - Nausea Clinical Trials

Effect of Orange Aroma on Nausea, Vomiting and Anxiety During Autologous Stem Cell Transplantation

Start date: March 28, 2015
Phase: N/A
Study type: Interventional

Patients undergoing stem cell transplantation for the first time will be entered. Participants will be randomized to one of two study arms: Arm 1: intervention (routine care+ inhalation aromatherapy); Arm 2: Control (Routine care) Hypotheses: (1) Patients receiving inhalation aromatherapy will experience less severe nausea and less frequent vomiting episodes than those receiving only routine care; and (2) patients receiving inhalation aromatherapy will demonstrate lower anxiety levels just after AHSCT than those receiving only routine care.

NCT ID: NCT04260659 Completed - Obesity Clinical Trials

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy

Start date: February 4, 2020
Phase: Phase 4
Study type: Interventional

Opioid free anesthesia is an anesthetic technique, in which administration of multimodal analgesia and sympathicolytics provides hemodynamic stability without use of opioids. Such management may be beneficial to the obese patients undergoing laparoscopic sleeve gastrectomy. Our study aims to compare opioid free anesthesia in such patients with standard, short-acting opioid based.

NCT ID: NCT04240236 Completed - Clinical trials for Postoperative Nausea and Vomiting

Scalp Blocks Effect on Postoperative Nausea & Vomiting After Craniotomy

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

In this study, the investigators hypothesize that preemptive scalp block in neurosurgical patients may decrease incidence of PONV after craniotomy through decreasing intraoperative inhalational agents' concentration and decreasing intraoperative opioids requirements, with better intraoperative hemodynamics and lesser recovery time

NCT ID: NCT04232423 Completed - Clinical trials for Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis

Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

OLN-EME
Start date: March 1, 2020
Phase: Phase 3
Study type: Interventional

To investigate that olanzapine can reduced side effect about nausea and vomiting in women with gynecologic cancers receiving carboplatin-based regimen by using olanzapine and placebo

NCT ID: NCT04155931 Completed - Clinical trials for Postoperative Nausea and Vomiting

The Effect of Intraoperative Body Temperature on Postoperative Nausea and Vomiting in Pediatric Patients

Start date: November 7, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of our study was to investigate the effects of changes in body temperature in the perioperative period on postoperative nausea and vomiting.

NCT ID: NCT04146090 Completed - Quality of Life Clinical Trials

Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy

Start date: October 23, 2019
Phase: N/A
Study type: Interventional

Background. Many studies have demonstrated reduced postoperative pain in patients undergoing lower pneumoperitoneum pressure level during laparoscopic cholecystectomy. However, most of them has shown a high risk of bias and low or very low quality of evidence. Considering the need to evaluate, not only the postoperative pain, but the effect of anesthesia and surgery on patient recovery and satisfaction, we have designed a prospective, randomised and double-blinded study to evaluate the quality of recovery, using the Quality of Recovery Questionnaire (QoR-40), in patients undergoing LC under low-pressure or standard pressure pneumoperitoneum. Methods. Eighty patients aged 18 to 65 years of age will be randomised into 2 groups: LP (low-pressure - 10mmHg) or S (standard - 14 mmHg) enrolled in the study. Anesthesia will be induced with remifentanil, propofol and rocuronium and the maintenance will be achieved with sevoflurane and remifentanil Anesthesiologists and surgeons will not have access to insufflation pressure display. The primary outcome will be assessed using the Quality of Recovery Questionnaire (QoR-40) which is a 40-item quality of recovery scoring system. In addition, the intraoperative rocuronium consumption, time to eye opening (time from the discontinuation of anesthetics to eye opening), post-operative nausea and vomiting, pain score, analgesic use, and length of PACU stay (time to Aldrete score ≥ 9) will be recorded.